(Q64625984)
Statements
Study to Investigate Which Clinical Risk Factors Are Considered by Physicians When Conducting Overall Febrile Neutropenia Risk Assessments for Patients Receiving Chemotherapy With an Intermediate (10% - 20%) Febrile Neutropenia Risk. (English)
0 references
December 2012
0 references
December 2013
0 references
1,007
0 references
18 year
0 references